Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yuzhu herbal tea is a botanical preparation derived from the dried rhizome of *Polygonatum odoratum* (Mill.) Druce, a plant widely utilized in Traditional Chinese Medicine (TCM) for its 'Yin-nourishing' and 'lung-moistening' properties. In the context of modern clinical research, it is being investigated for its potential therapeutic benefits in managing diabetes mellitus. The tea contains bioactive components such as polysaccharides, steroidal saponins, and flavonoids, which are thought to exert hypoglycemic effects by improving insulin sensitivity and inhibiting carbohydrate-digesting enzymes. The clinical evaluation of this herbal tea is supported by institutions such as Nanchong Central Hospital and Minhong Technology, with funding from the Department of Science and Technology of Sichuan Province.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yuzhu herbal tea.